1992•Birkhäuser Boston eBooksRequires access

Excitotoxicity and Neurodegenerative Disorders

Charles F. Zorumski, John W. Olney

Open publisher page 1 citations

Abstract

The excitatory amino acids (EAA) glutamate (Glu) and aspartate (Asp) are now recognized as key participants in a variety of physiologic and pathologic processes. On the one hand, these agents are likely to function as neurotransmitters at the majority of fast excitatory synapses in the vertebrate central nervous system (CNS), playing roles in normal synaptic transmission (Collingridge and Lester, 1989; Mayer and Westbrook, 1987a) and several forms of synaptic plasticity (Kuba and Kumamoto, 1990). Yet exposure of neurons to these agents clearly has toxic consequences, prompting hypotheses regarding the involvement of EAA in human neuro-degenerative syndromes (Olney, 1990). In this chapter we will review evidence linking EAA to specific neuropsychiatric syndromes. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

About this research paper

What this paper is about

The excitatory amino acids (EAA) glutamate (Glu) and aspartate (Asp) are now recognized as key participants in a variety of physiologic and pathologic processes. On the one hand, these agents are likely to function as neurotransmitters at the majority of fast excitatory synapses in the vertebrate central nervous system (CNS), playing roles in normal synaptic transmission (Collingridge and Lester, 1989; Mayer and Westbrook, 1987a) and several forms of synaptic plasticity (Kuba and Kumamoto, 1990). Yet exposure of neurons to these agents clearly has toxic consequences, prompting hypotheses regarding the involvement of EAA in human neuro-degenerative syndromes (Olney, 1990). In this chapter we will review evidence linking EAA to specific neuropsychiatric syndromes. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The excitatory amino acids (EAA) glutamate (Glu) and aspartate (Asp) are now recognized as key participants in a variety of physiologic and pathologic processes. On the one hand, these agents are likely to function as neurotransmitters at the majority of fast excitatory synapses in the vertebrate central nervous system (CNS), playing roles in normal synaptic transmission (Collingridge and Lester, 1989; Mayer and Westbrook, 1987a) and several forms of synaptic plasticity (Kuba and Kumamoto, 1990). Yet exposure of neurons to these agents clearly has toxic consequences, prompting hypotheses regarding the involvement of EAA in human neuro-degenerative syndromes (Olney, 1990). In this chapter we will review evidence linking EAA to specific neuropsychiatric syndromes. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Key concepts: Excitotoxicity, Neuroscience, Excitatory amino-acid transporter, Glutamate receptor, Neurotransmission, Excitatory postsynaptic potential, Synaptic plasticity, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Excitotoxicity and Neurodegenerative Disorders — Research Paper | ScholarLens